Date: May 29, 2pm EDT
NeoGenomics' medical staff ensure that
your results matter.
Interview: CEO Douglas VanOort talks about growing NeoGenomics into a leader in US cancer Genetics.
Click below to see open positions
HemeFISH New & Expanded Panels:
Eosinophilia, MPN, CLL, MDS, AML
Investor News: view the Q1 2013 Earnings Release and listen to the Q1 2013 Earnings Call.